Sodium ferric gluconate (SFG) in complex with sucrose for IV infusion: Bioequivalence of a new generic product with the branded product in healthy volunteers

Current Medical Research and Opinion

Volumn 27, Issue 8, 2011, Pages 1653-1657

  Baribeault, David ^a  

^a McKesson Corporation   (United States)

Author keywords

Equivalency, therapeutic; Ferric gluconate; Ferrlecit; Nulecit; Pharmacokinetics

Indexed keywords

FERRIC GLUCONATE; IRON; NULECIT; SUCROSE; TRANSFERRIN; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; IRON BLOOD LEVEL; MALE; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; OPEN STUDY; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE;

ADULT; ANEMIA, IRON-DEFICIENCY; DRUGS, GENERIC; ERYTHROPOIETIN, RECOMBINANT; FEMALE; FERRIC COMPOUNDS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; RENAL DIALYSIS; SUCROSE; SWEETENING AGENTS; TIME FACTORS;

EID: 79960423091     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2011.597738     Document Type: Article

References (7)

1. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis 2006;47:S11-145.
2. Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005; 352:1011-23.
3. Coyne DW, Kapoian T, Suki W, et al. Ferric gluconate is highly efficacious in anemic hemodialysis patients with high serum ferritin and low transferrin saturation: results of the Dialysis Patients' Response to IV Iron with Elevated Ferritin (DRIVE) study. J Am Soc Nephrol 2007;18:975-84. (Pubitemid 46434515)
4. Nissenson AR, Lindsay RM, Swan S, et al. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial. Am J Kidney Dis 1999;33:471-82. (Pubitemid 29107024)
5. Ferrlecit [prescribing information]. Bridgewater, NJ, USA: sanofi-aventis US LLC, 2010.
6. Nulecit [prescribing information]. Corona, CA, USA: Watson Pharma Inc., 2010.
7. Center for Drug Evaluation and Research. U.S. Food and Drug Administration. Guidance for Industry: Statistical Approaches to Establishing Bioequivalence. 2001